← Back to Search

Behavioral Nudge for Genetic Predisposition

N/A
Recruiting
Led By Katherine L Nathanson, MD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or older
diagnosed with one of the study conditions
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights

Summary

This trial aims to find new ways to deliver genetic testing results that can change medical management beyond traditional genetic counseling visits. The study will use non-geneticist clinicians and patient nudges in a randomized clinical

Who is the study for?
Adults diagnosed with specific conditions like Alzheimer's, various heart diseases, and genetic predispositions that can change medical management based on genetic testing results. Participants must be over 18 years old.
What is being tested?
The trial is testing a new approach to genomic medicine using electronic health records (EHR) to nudge clinicians and patients towards the use of genetic testing. It involves direct test ordering, EHR algorithms for patient identification, and behavioral economics methods.
What are the potential side effects?
Since this trial focuses on behavioral nudges rather than medications or invasive procedures, traditional physical side effects are not expected. However, there may be psychological impacts or changes in healthcare decisions due to the nudging.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have been diagnosed with a condition being studied.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of Genetic Testing
Secondary outcome measures
Rate of Clinician actions
Rate of Genetic Test Orders/Referrals
Rate of Pathogenic variants and VUS
+1 more

Trial Design

6Treatment groups
Active Control
Group I: Clinician BPA refer plus patient nudgeActive Control1 Intervention
Clinician will receive a nudge to refer patient for genetic testing and the patient will receive a text message encouraging them to speak with their clinician about genetic testing.
Group II: Clinician nudge, referActive Control1 Intervention
Clinician will receive a nudge to refer the patient for genetic testing.
Group III: Generic BPA; no nudgeActive Control1 Intervention
Usual care
Group IV: Clinician nudge, orderActive Control1 Intervention
Clinician will receive a nudge to order genetic testing for the patient.
Group V: Patient nudgeActive Control1 Intervention
The patient will receive a text message encouraging them to speak with their clinician about genetic testing.
Group VI: Clinician BPA order plus patient nudgeActive Control1 Intervention
Clinician will receive a nudge to order genetic testing for the patient and the patient will receive a text message encouraging them to speak with their clinician about genetic testing.

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,053 Previous Clinical Trials
43,012,127 Total Patients Enrolled
Katherine L Nathanson, MDPrincipal InvestigatorUniversity of Pennsylva
1 Previous Clinical Trials
1,238 Total Patients Enrolled
Robert Schnoll, PhDPrincipal InvestigatorUniversity of Pennsylva
3 Previous Clinical Trials
1,252 Total Patients Enrolled
~667 spots leftby Jun 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top